Immunic Inc. buy Brookline Capital Management
Start price
05.04.24
/
50%
€1.27
Target price
05.04.25
€9.25
Performance (%)
-28.99%
End price
06.04.25
€0.90
Summary
This prediction ended on 06.04.25 with a price of €0.90. The prediction for Immunic Inc. disappointed with a performance of -28.99%. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunic Inc. | -7.986% | -7.986% | -51.017% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten